UNSPSC 51182433: Neridronic acid

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C6H17NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8U27U3RIN4, chemically known as 6-amino-1-hydroxyhexane-1,1-diphosphonate but generally known as neridronic acid, which bears US NIH Compound Identifier 71237. European Medicines Agency schedules Neridronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09205MIG.

The term NERIDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). As of Q4 2014, NERIDRONIC ACID remains the US FDA Preferred Term for this commodity. Neridronic acid bears US NLM identifiers UMLS ID C1882065 and NCI Concept Code C66230. SMILES: P(=O)(O)(O)C(P(=O)(O)O)(O)CCCCCN.

UNSPSC 51182433 Neridronic acid is a Commodity code identifying a specific pharmaceutical active ingredient — a bisphosphonate compound — that state and local health systems, correctional facilities, and public health agencies procure for treatment of bone-density disorders and related conditions. The source provides no recent state and local contract opportunities under this code and does not identify active solicitation activity.

Without posted opportunities to characterize issuing-body concentration, geographic spread, or representative procurement patterns, no further assessment is possible from the available record.